The TNF-α, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis

  • Yu Yang
  • Chao Luo
  • R. Feng
  • Sheng Bi
Original Paper



TNF-α-308 G/A, TNF-α-238 G/A, IL-1B-31 T/C, IL-1B-511 C/T, and IL-10-1082 G/A polymorphisms have been reported to influence the risk for hepatocellular carcinoma (HCC) in many studies; however, the results still remains controversial and ambiguous. The aim of this study was to determine more precise estimations for the relationship between TNF-α, IL-1B, and IL-10 polymorphisms and the risk for HCC by meta-analysis.


Electronic searches for all publications were conducted on associations between these variants and HCC in several databases through September 2010. Odds ratios (OR) with 95% confidence intervals (95% CI) were calculated to estimate the strength of this association in a random-effect model. Twenty studies were identified, involving 2,763 HCC patients and 4,152 controls.


This meta-analysis showed significant association between TNF-α-308 polymorphism and HCC (AA + GA vs. GG: OR = 1.74, 95% CI = 1.12–2.72). In Caucasian and Asian subgroups, OR values (95% CI) were 1.49 (0.58–3.82) and 1.84 (1.06–3.20), respectively. While the ORs for TNF-α-238 G/A, IL-1B-31 T/C, -511 C/T and IL-10-1082 G/A polymorphisms and HCC were 1.37 (0.95–2.00), 1.24 (0.99–1.55), 1.12 (0.66–1.88) and 0.91 (0.74–1.12), respectively. The sensitivity analysis further strengthened the overall strong positive correlations. No publication bias was observed in this study.


TNF-α-308 G/A polymorphism is assumed to confer a higher risk for HCC, especially in Asian population. TNF-α-238 G/A, IL-1B-31 T/C, -511 C/T, and IL-10-1082 G/A polymorphisms were not detected to be related to the risk for HCC.


Meta-analysis Polymorphism TNF-α Interleukin Hepatocellular carcinoma 



This work was supported by Harbin Special Funds for Research of Scientific and Technological Innovative Talents (No. RC2011QN004139).

Conflict of interest

The authors do not have any conflicts of interest to report with for this manuscript.


  1. Akkiz H, Bayram S, Bekar A, Ozdil B, Akgollu E, Sumbul AT et al (2009) G-308A TNF-alpha polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study. Cancer Epidemiol 33:261–264PubMedCrossRefGoogle Scholar
  2. Anderson GM, Nakada MT, DeWitte M (2004) Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr Opin Pharmacol 4:314–320PubMedCrossRefGoogle Scholar
  3. Ben-Ari Z, Mor E, Papo O, Kfir B, Sulkes J, Tambur AR et al (2003) Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 98:144–150PubMedCrossRefGoogle Scholar
  4. Bouzgarrou N, Hassen E, Farhat K, Bahri O, Gabbouj S, Maamouri N et al (2009) Combined analysis of interferon-gamma and interleukin-10 gene polymorphisms and chronic hepatitis C severity. Hum Immunol 70:230–236PubMedCrossRefGoogle Scholar
  5. Chen CC, Yang SY, Liu CJ, Lin CL, Liaw YF, Lin SM et al (2005) Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int J Epidemiol 34:1310–1318PubMedCrossRefGoogle Scholar
  6. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867PubMedCrossRefGoogle Scholar
  7. Hellmig S, Fischbach W, Goebeler-Kolve ME, Folsch UR, Hampe J, Schreiber S (2005) A functional promotor polymorphism of TNF-alpha is associated with primary gastric B-Cell lymphoma. Am J Gastroenterol 100:2644–2649PubMedCrossRefGoogle Scholar
  8. Heneghan MA, Johnson PJ, Clare M, Ho S, Harrison PM, Donaldson PT (2003) Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese. Int J Gastrointest Cancer 34:19–26PubMedCrossRefGoogle Scholar
  9. Hirankarn N, Kimkong I, Kummee P, Tangkijvanich P, Poovorawan Y (2006) Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection. World J Gastroenterol 12:776–779PubMedGoogle Scholar
  10. Ho SY, Wang YJ, Chen HL, Chen CH, Chang CJ, Wang PJ et al (2004) Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene. Cancer Causes Control 15:657–663PubMedCrossRefGoogle Scholar
  11. Huizinga TW, Westendorp RG, Bollen EL, Keijsers V, Brinkman BM, Langermans JA et al (1997) TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 72:149–153PubMedCrossRefGoogle Scholar
  12. Jang WH, Yang YI, Yea SS, Lee YJ, Chun JH, Kim HI et al (2001) The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 166:41–46PubMedCrossRefGoogle Scholar
  13. Jeng JE, Tsai JF, Chuang LY, Ho MS, Lin ZY, Hsieh MY et al (2007) Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia 9:987–992PubMedCrossRefGoogle Scholar
  14. Jeng JE, Tsai HR, Chuang LY, Tsai JF, Lin ZY, Hsieh MY et al (2009) Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma. Medicine (Baltimore) 88:349–357CrossRefGoogle Scholar
  15. Jung KW, Ha E, Yu GI, Kim SJ, Chung WJ, Jang BK et al (2009) TNFalpha promoter polymorphism is a risk factor for susceptibility in hepatocellular carcinoma in Korean population. Clin Chim Acta 407:16–19PubMedCrossRefGoogle Scholar
  16. Kummee P, Tangkijvanich P, Poovorawan Y, Hirankarn N (2007) Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J Viral Hepat 14:841–848PubMedGoogle Scholar
  17. Migita K, Miyazoe S, Maeda Y, Daikoku M, Abiru S, Ueki T et al (2005) Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection–association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J Hepatol 42:505–510PubMedCrossRefGoogle Scholar
  18. Nieters A, Yuan JM, Sun CL, Zhang ZQ, Stoehlmacher J, Govindarajan S et al (2005) Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer 103:740–748PubMedCrossRefGoogle Scholar
  19. Niro GA, Fontana R, Gioffreda D, Valvano MR, Lacobellis A, Facciorusso D et al (2005) Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection. Liver Int 25:1175–1181PubMedCrossRefGoogle Scholar
  20. Ognjanovic S, Yuan JM, Chaptman AK, Fan Y, Yu MC (2009) Genetic polymorphisms in the cytokine genes and risk of hepatocellular carcinoma in low-risk non-Asians of USA. Carcinogenesis 30:758–762PubMedCrossRefGoogle Scholar
  21. Okamoto K, Ishida C, Ikebuchi Y, Mandai M, Mimura K, Murawaki Y et al (2010) The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma. Intern Med 49:887–895PubMedCrossRefGoogle Scholar
  22. Parkin DM (2008) The global burden of urinary bladder cancer. Scand J Urol Nephrol Suppl 218:12–20PubMedCrossRefGoogle Scholar
  23. Sakamoto T, Higaki Y, Hara M, Ichiba M, Horita M, Mizuta T et al (2008) Interaction between interleukin-1beta -31T/C gene polymorphism and drinking and smoking habits on the risk of hepatocellular carcinoma among Japanese. Cancer Lett 271:98–104PubMedCrossRefGoogle Scholar
  24. Shin HD, Park BL, Kim LH, Jung JH, Kim JY, Yoon JH et al (2003) Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet 12:901–906PubMedCrossRefGoogle Scholar
  25. Tanaka Y, Furuta T, Suzuki S, Orito E, Yeo AE, Hirashima N et al (2003) Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan. J Infect Dis 187:1822–1825PubMedCrossRefGoogle Scholar
  26. Tarao K, Rino Y, Ohkawa S, Shimizu A, Tamai S, Miyakawa K et al (1999) Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. Cancer 86:589–595PubMedCrossRefGoogle Scholar
  27. Wang Y, Kato N, Hoshida Y, Yoshida H, Taniguchi H, Goto T et al (2003) Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37:65–71PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.The Central Laboratory, Department of NeurologyThe First Affiliated Hospital of Harbin Medical UniversityHarbinPeople’s Republic of China
  2. 2.Department of OncologyThe 2nd Affiliated Hospital of Harbin Medical UniversityHarbinPeople’s Republic of China
  3. 3.Department of Hygienic Toxicology, School of Public HealthHarbin Medical UniversityHarbinPeople’s Republic of China
  4. 4.Division of AIDS/STD Control and PreventionHarbin Center for Disease Control and PreventionHarbinPeople’s Republic of China
  5. 5.Department of Nutrition and Food Hygiene, School of Public HealthHarbin Medical UniversityHarbinPeople’s Republic of China

Personalised recommendations